Set Your Sights On AbCellera Biologics Inc (NASDAQ: ABCL)’S Upside Potential
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $3.53, with 11.02 million shares of worth about $38.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.28% during that period and on January 22, 2025 the price saw a […]
Growing Through Challenges? – AbCellera Biologics Inc (ABCL)
Currently, there are 295.16M common shares owned by the public and among those 221.93M shares have been available to trade. The company’s stock has a 5-day price change of -16.31% and 6.95% over the past three months. ABCL shares are trading -5.46% year to date (YTD), with the 12-month market performance down to -49.17% lower. […]
Analysts Update Their Price Forecasts For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $3.03, with 3.6 million shares of worth about $10.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.21% during that period and on January 08, 2025 the price saw a […]
AbCellera Biologics Inc (ABCL): Not A Time To Panic Nor Freeze
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $3.03, with 2.99 million shares of worth about $9.04 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.21% during that period and on December 26, 2024 the price saw a […]
Following The Money: Institution’s Growing Stake In AbCellera Biologics Inc (NASDAQ: ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.69, with 4.47 million shares of worth about $12.03 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.50% during that period and on December 18, 2024 the price saw a […]
Tomorrow Is Not Likely To Be Same For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $2.95, with 3.67 million shares of worth about $10.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.41% during that period and on December 12, 2024 the price saw a […]
